Avita has announced today a development and distribution agreement with Regenity Biosciences for a resorbable collagen dermal matrix.
The newly-developed matrix is expected to receive 510(k) clearance later this year and Avita intends to trial the matrix, versus other commercially available matrices, in combination with Recell in two-stage grafting. An additional trial will assess the matrix combined with Recell in a single stage grafting procedure.
The source of collagen isn’t specified but other Regenity bioresorbable collagen products that have been cleared by the FDA are sourced from bovine dermis.
PNV - Banter and General Comments, page-12170
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
0.065(2.43%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.75 | $2.66 | $1.709M | 629.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 29124 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.75 | 113563 | 24 |
View Market Depth
| Last trade - 12.03pm 01/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |